VERTEX PHARMACEUTICALS INC / MA — All Filings
1,003 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-C
10-K
10-K/A
10-K405
10-Q
10-Q/A
144
3
3/A
4
4/A
424B1
424B2
424B3
424B5
425
5
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NO ACT
POS AM
PRE 14A
PX14A6G
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0000875320-26-000060 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0000875320-26-000078 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0000875320-26-000064 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0000875320-26-000066 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0000875320-26-000068 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0000875320-26-000070 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0000875320-26-000072 | Feb 18, 2026 | Feb 13, 2026 |
| 144 | — | 0001959173-26-001111 | Feb 18, 2026 | — |
| 4 | FORM 4 | 0000875320-26-000076 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0000875320-26-000074 | Feb 18, 2026 | Feb 13, 2026 |
| 144 | — | 0001959173-26-001089 | Feb 18, 2026 | — |
| 144 | — | 0001959173-26-001066 | Feb 17, 2026 | — |
| 144 | — | 0001959173-26-001046 | Feb 17, 2026 | — |
| 144 | — | 0001959173-26-001037 | Feb 17, 2026 | — |
| 144 | — | 0001959173-26-001034 | Feb 17, 2026 | — |
| 10-K | 10-K | 0000875320-26-000056 | Feb 13, 2026 | Dec 31, 2025 |
| 144 | — | 0001959173-26-000975 | Feb 13, 2026 | — |
| 144 | — | 0001959173-26-000976 | Feb 13, 2026 | — |
| 144 | — | 0001959173-26-000977 | Feb 13, 2026 | — |
| 4 | FORM 4 | 0000875320-26-000054 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0000875320-26-000036 | Feb 12, 2026 | Feb 10, 2026 |
| SCHEDULE 13G/A | — | 0001422848-26-000023 | Feb 12, 2026 | — |
| 8-K | 8-K | 0000875320-26-000034 | Feb 12, 2026 | — |
| 4 | FORM 4 | 0000875320-26-000038 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0000875320-26-000040 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0000875320-26-000042 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0000875320-26-000044 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0000875320-26-000046 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0000875320-26-000048 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0000875320-26-000050 | Feb 12, 2026 | Feb 10, 2026 |
| 4 | FORM 4 | 0000875320-26-000052 | Feb 12, 2026 | Feb 10, 2026 |
| 144 | — | 0001959173-26-000856 | Feb 11, 2026 | — |
| 144 | — | 0001959173-26-000845 | Feb 11, 2026 | — |
| 144 | — | 0001959173-26-000850 | Feb 11, 2026 | — |
| 144 | — | 0001959173-26-000853 | Feb 11, 2026 | — |
| 3 | FORM 3 | 0000875320-26-000030 | Feb 3, 2026 | Feb 1, 2026 |
| 4 | FORM 4 | 0001856587-26-000002 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000010 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000012 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000014 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000016 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000018 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000020 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000022 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000024 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000026 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000028 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0000875320-26-000006 | Jan 20, 2026 | Jan 15, 2026 |
| 4 | FORM 4 | 0000875320-26-000008 | Jan 20, 2026 | Jan 15, 2026 |
| 4 | FORM 4 | 0000875320-26-000004 | Jan 9, 2026 | Jan 7, 2026 |